Report an error   

Submitted: 18 August 2017 Modified: 18 August 2017
HERDIN Record #: NCR-JAFES-17081816485667

Diabetes mellitus and prediabetes in patients with hepatocellular carcinoma in a tertiary Philippine hospital.

Elizabeth Paz-Pacheco,

See More

Background. Diabetes mellitus (DM) has been shown to be associated with an increased risk for hepatocellular carcinoma (HCC). DM and obesity are coexisting conditions that can increase the risk and severity of nonalcoholic fatty liver disease (NAFLD), leading to HCC even in the absence of cirrhosis. With the rising incidence of HCC and DM worldwide, it is important to identify the clinical characteristics of individuals with DM among those with HCC in our local setting.

Methodology. This is a retrospective, analytical, cross-sectional study involving patients with HCC seen at The Medical City's Center for Liver Disease Management and Transplantation from January 2010 to December 2014. A chart review was conducted and patients were grouped according to the presence or absence of DM. Data on demographics, body mass index (BMI), comorbidities, social and family history, risk factors for liver disease, and laboratory test results were gathered. STATA 12.0 was used for data analysis.

Results. We included 180 patients with HCC in the analysis. The prevalence of type 2 DM and prediabetes was 52.78%. The median age of patients with DM and prediabetes was 65 years, and 58 years for patients without DM (p=0.002). The average BMI was 27.35 ± 4.68 for patients with DM, and 25.04 ± 5.11 for those without DM (p=0.002). Among the patients without DM, 50.59% had hepatitis B virus (HBV) infection compared to 24.21% of patients with DM (p=0.000). Twenty one percent of patients with DM had cryptogenic cirrhosis compared to 8.24% of patients without DM (p=0.016). Patients with DM had a higher proportion of hypertension (66.32% vs 42.35%, p=0.001) and dyslipidemia (48.42% vs 10.59%, p=0.000).

Conclusion. The prevalence of DM and prediabetes among HCC patients is higher in our institution compared to findings from previous studies. HCC patients with DM were older, and had increased BMI, higher proportion of hypertension and dyslipidemia, lower incidence of HBV infection, and higher incidence of cryptogenic cirrhosis.


To determine the prevalence of DM among Filipino patients with HCC at our institution, determine their demographic and clinical profile, and compare the characteristics of HCC patients with and without DM.

Publication Type
Publication Sub Type
Journal Article, Original
Journal of the ASEAN Federation of Endocrine Societies
Publication Date
May-October 2017


To determine the prevalence of DM among Filipino patients with HCC at our institution, determine their demographic and clinical profile, and compare the characteristics of HCC patients with and without DM.

LocationLocation CodeAvailable FormatAvailability (632) 6373162 Fulltext External Link (View)
1. (2011, November 30). International Agency for Research on Cancer, World Health Organization. GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. WHO. . Retrieved from:
2. Yuen, MF , Hou, JL , Chutaputti, A . "Hepatocellular carcinoma in the Asia pacific region" J Gastroenterol Hepatol 24(3): 346-53, 2009
3. El-Serag, HB . "Hepatocellular carcinoma" N Engl J Med 365(12): 1118-27, 2011
4. El-Serag, HB , Tran, T , Everheart , JE . "Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma" Gastroenterology 126(2): 460-8, 2004
5. Tolman, KG , Fonseca, V , Dalpiaz, A , Tan, MH . "Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease" Diabetes Care 30(3): 734-43, 2007
6. Angulo, P . "Nonalcoholic fatty liver disease" N Engl J Med 346(16): 1221-31, 2002
7. Khan, FZ , Perumpail, RB , Wong, RJ , Ahemed, A . "Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma" World J Hepatol 7(18): 2155-2161, 2015
8. Bhatt, HB , Smith, RJ . "Fatty liver disease in diabetes mellitus" Hepatobiliary Surg Nutr 4(2): 101-8, 2015
9. De Lusong, MAA , Labio, E , Daez, L , Gloria, V . "Non-alcoholic fatty liver disease in the Philippines: Comparable with other nations?" World J Gastroenterol 14(6): 913-7, 2008
10. Andrada, PLL , Tan, H . "Prevalence of metabolic syndrome among patients with non-alcoholic fatty liver disease" Phil J Gastroenterol 2, 14-8, 2006
11. Manuel, JJ , Palugod , E , Cervantes, J . "The association of risk factors in the development of non-alcoholic fatty liver disease (NAFLD) in Filipino patients with type 2 diabetes mellitus in a tertiary center" Philipp J Intern Med 45, 135-43, 2007
12. El-Serag, HB , Hampel, H , Javadi, F . "The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence" Clin Gastroenterol Hepatol 43(3): 369-80, 2006
13. Lucas, ZD , Pangan, CP , Patal, PC , Ong, J . "The clinical profile of hepatocellular carcinoma patients at the Philippine General Hospital" Philipp J Intern Med 47(1): 1-9, 2009
14. Daez, MLO , Ong, JP , Lomboy, ARB . "Demographic profile and treatment outcomes of Filipino patients with hepatocellular carcinoma in a liver tumor registry" Acta Med Philipp 48(1): 4-8, 2014
15. Wong, SN , Ong, JP , Labio, MED . "Hepatitis B infection among adults in the Philippines: A national seroprevalence study" World J Hepatol 5(4): 214-9, 2013
16. Peacock, JL , Peacock, P . Oxford Handbook of Medical Statistics. New York: Oxford University Press inc., 2011. 58-9.
17. Hassan, MM , Curley, SA , Li, D . "Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma" Cancer 116(8): 1938-46, 2010
18. Taura, N , Ichikawa, T , Miyaaki, H . "Prevalence of type 2 diabetes mellitus in Japanese patients with hepatocellular carcinoma" Exp Ther Med 2(1): 81-4, 2011
19. Jimeno, CA , Kho, SA , Matawaran, BJ . "Prevalence of diabetes mellitus and pre-diabetes in the Philippines: A sub-study of the 7th National Nutrition and Health Survey (2008)" Philipp J Intern Med 53(2): 1-8, 2015
20. Rahman, R , Hammoud, GA , Almashhrawi, AA . "Primary hepatocellular carcinoma and metabolic syndrome: An update" World J Gastrointest Oncol 5(9): 186-94, 2013
21. Zhang, H , Gao, C , Fang, L , Yao, S . "Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus" World J Gastroenterol 19(15): 2395-2403, 2013
22. Vigneri, P , Frasca, F , Sciacca, L . "Diabetes and cancer" Endocr Relat Cancer 16(4): 1103-23, 2009
23. Siegel, AB , Lim, EA , Wang, S . "Diabetes, body mass index and outcomes in hepatocellular carcinoma patients undergoing liver transplantation" Transplantation 94(5): 539-43, 2012
24. Donadon, V , Balbi, M , Valent, F . "Glycated hemoglobin and antidiabetic strategies as risk factors for hepatocellular carcinoma" World J Gastroenterol 16(24): 3025-32, 2010
25. (). WHO NCD Surveillance Strategy. WHO. . Retrieved from:

Copyright © One Window Project 2018. All rights reserved.